Related Articles
Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
Pan‑RAF inhibitor LY3009120 is highly synergistic with low‑dose cytarabine, but not azacitidine, in acute myeloid leukemia with <em>RAS</em> mutations
Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses
Panel‑based next‑generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings